Hokuto Corporation

2026/08/21 Updated
Market Cap: $415.8M (¥66.1B)
Stock Price: $13.27 (¥2,109)
Exchange Rate: 1 USD = ¥158.98

Full Fiscal Year 2026 Earnings Forecast Revision | Revenue of ¥85,900 million (YoY +1.4%)

Hokuto revised its consolidated and individual earnings forecasts for the full fiscal year ending March 2026, upwardly adjusting sales to approximately ¥85,900 million. Operating income and net income are also expected to increase significantly, driven by a weaker yen and promotional activities.

Importance:
Page Updated: May 8, 2026
IR Disclosure Date: May 8, 2026

Key Figures

  • Sales Revenue: ¥85,900 million (YoY +1.4%)
  • Operating Income: ¥7,000 million (YoY +20.1%)
  • Net Income Attributable to Owners of Parent: ¥7,000 million (YoY +21.5%)

AI要約

Overview of Performance

Hokuto has upwardly revised its full-year consolidated and individual earnings forecasts for the fiscal year ending March 2026. In its core domestic mushroom business, increased health consciousness and cost-saving tendencies have supported advanced strategies and promotional activities, leading to performance surpassing initial plans. The continued yen depreciation has also contributed to foreign exchange gains, with expected sales of ¥85,900 million, operating income of ¥7,000 million, and net income of ¥7,000 million.

Outlook and Impact

Thanks to the effects of yen depreciation and promotional activities, earnings are expected to remain robust. The increase in sales and profits is anticipated to enable shareholder returns and business expansion. The company plans to respond to changing market conditions by continuing product proposals and promotional efforts aligned with rising health consciousness, aiming to strengthen its profit base.

Sales Revenue Trends

Operating Income Trends

Net Income Trends

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Hokuto Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →